A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma

JX-594 is a targeted and granulocyte macrophage-colony stimulating factor (GM-CSF)-expressing oncolytic poxvirus designed to selectively replicate in and destroy cancer cells through viral oncolysis and tumor-specific immunity. In order to study the mechanisms-of-action (MOA) of JX-594 in humans, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hwang, Tae-Ho, Moon, Anne, Burke, James, Ribas, Antoni, Stephenson, Joe, Breitbach, Caroline J, Daneshmand, Manijeh, De Silva, Naomi, Parato, Kelley, Diallo, Jean-Simon, Lee, Yeon-Sook, Liu, Ta-Chiang, Bell, John C, Kirn, David H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188739/
https://ncbi.nlm.nih.gov/pubmed/21772252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados